Authors' response: The role of risedronate in osteopenia in Crohn's disease

Gut. 2015 Jan;64(1):185-6. doi: 10.1136/gutjnl-2014-306746. Epub 2014 Feb 25.

Authors

Ad A van Bodegraven¹, Birgit I Witte², Paul Lips³; Crohn and Bone Study Group of the Dutch Initiative on Crohn and Colitis (ICC)

Affiliations

¹ Department of Gastroenterology and Hepatology, VUmc, Amsterdam, The Netherlands.
² Department of Epidemiology and Biostatistics, VUmc, Amsterdam, The Netherlands.
³ Endocrine Section, Department of Internal Medicine, VUmc, Amsterdam, The Netherlands.

PMID: 24569060
DOI: 10.1136/gutjnl-2014-306746

No abstract available

Keywords: BONE DISEASE; BONE MINERAL DENSITY; CALCIUM; CROHN'S DISEASE; VITAMINS.

Publication types

Letter
Comment

MeSH terms

Bone Density Conservation Agents / therapeutic use*
Bone Diseases, Metabolic / drug therapy*
Calcium / therapeutic use*
Crohn Disease / complications*
Dietary Supplements*
Etidronic Acid / analogs & derivatives*
Female
Humans
Male
Vitamin D / therapeutic use*

Substances

Bone Density Conservation Agents
Vitamin D
Etidronic Acid
Calcium